Home Heart Attack How Wegovy® Reduces Heart Attack & Stroke Risk | FDA-Approved GLP-1 for Heart Health

How Wegovy® Reduces Heart Attack & Stroke Risk | FDA-Approved GLP-1 for Heart Health

by Admin1122



🫀 Protect Your Heart with the Latest Science

Cardiovascular disease continues to be a leading cause of death, but there’s new hope. 💡 The FDA has approved Wegovy® (semaglutide) to help reduce the risk of serious heart events — including heart attack and stroke — in adults with obesity or overweight and existing heart disease.

In this video, we break down how this breakthrough treatment works and what it means for heart health.

🔗 Learn more:

Learn more about each medication’s benefits and risks by visiting the manufacturer’s Prescribing Information webpage prior to starting any weight loss program.

#HeartHealth #Wegovy #HeartDiseaseAwareness #MetabolicHealth #ObesityTreatment #Semaglutide #Longevity #HealthyHeart #Wellness

source

You may also like

Leave a Comment

Verified by MonsterInsights